Clinical and statistical assessment of suicidal ideation and behavior in pharmaceutical trials.

Abstract

In the past two decades, the potential association between the risk of suicidal ideation and behavior and the clinical use of pharmaceutical products has been debated among industry, regulators, and academia. A better understanding of the possible effects-favorable, unfavorable, or neutral-of pharmaceuticals on the risk of suicidal ideation and behavior may… (More)
DOI: 10.1038/clpt.2011.144

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.